This hypothesis has been directly tested by the finding that a small TGF-β inhibitor rescues the abnormal maturation (and myelofibrosis) in Gata1low mice by increasing the levels of Gata1 mRNA while reducing those of Gata2 (31, 55). The gene discussed is TGFB1; the disease is myelofibrosis.